Seeing Is Believing
with an average price target of $2.61. This is a potential upside of $2.61 (0%) from yesterday's end of day stock price of $0.
ZIOPHARM Oncology's activity chart (see below) currently has 0 price targets and 4 ratings on display.
Most recent stock forecast was given by DAVID NOVAK from RAYMOND JAMES on 10-Aug-2021. First documented stock forecast 26-Mar-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$3
$2.17 (261.45%)
3 years 8 months 11 days ago
(10-Aug-2021)
0/2 (0%)
$0.74 (31.70%)
Buy
$7
$6.17 (743.37%)
$7
3 years 8 months 11 days ago
(10-Aug-2021)
0/3 (0%)
$3.8 (144.78%)
Buy
$5
$4.17 (502.41%)
$7
4 years 1 months 9 days ago
(12-Mar-2021)
0/2 (0%)
$2.17 (63.99%)
Hold
$15
9 years 9 months 30 days ago
(22-Jun-2015)
0/4 (0%)
$3.74 (33.21%)
What is ZIOP (ZIOPHARM Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on ZIOP (ZIOPHARM Oncology) with a proven track record?
Which analyst has the current lower performing score on ZIOP (ZIOPHARM Oncology) with a proven track record?
Which analyst has the most public recommendations on ZIOP (ZIOPHARM Oncology)?
Which analyst is the currently most bullish on ZIOP (ZIOPHARM Oncology)?
Which analyst is the currently most reserved on ZIOP (ZIOPHARM Oncology)?